ANTICOV

Identification of early treatments to prevent progression of COVID-19 to severe disease and limit disease transmission


The ANTICOV clinical trial responds to the urgent need to identify treatments that can be used to treat mild and moderate cases of COVID-19 early and prevent spikes in hospitalizations that could overwhelm fragile and already overburdened health systems in low-resource settings.

More project information coming soon...

For further details please visit the AntiCov website.

Zu sehen ist ein freundlicher, selbstbewusster und erfahrener Forscher aus dem europäischen Raum.
Head of Department

Prof. Dr. Jürgen May

Telefon: +49 40 285380-402

E-Mail: may@bnitm.de

  • Logo DZIF